[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Metaproterenol Inhalation |
Alupent Inhalation |
Clinical Trial: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial Assessing the Rate of Decline of Lung Function with Tiotropium (Spiriva®) 18 Mcg Inhalation Capsule Once Daily in Patients with Chronic Obstructive Pulmonary Disaese (COPD).
This study is no longer recruiting patients.
|
Purpose
The primary objective of this trial is to determine whether daily treatment with tiotropium (Spiriva®, Bromuro de Tiotropio®) inhalation capsule via HandiHaler® reduces the rate of decline in lung funtion over time in patients with COPD.
| Condition | Intervention | Phase |
|---|---|---|
| Pulmonary Disease, Chronic Obstructive | Drug: tiotropium | Phase III |
MedlinePlus related topics: COPD (Chronic Obstructive Pulmonary Disease)
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment
Official Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial Assessing the Rate of Decline of Lung Function with Tiotropium 18 Mcg Inhalation Capsule Once Daily in Patients with Chronic Obstructive Pulmonar Disease (COPD).
Further Study Details:
Primary Outcomes: The co-primary endpoints are:yearly rate of decline in pre and post bronchodilator FEV1 from day 30 (steady state) until completion of double-blind treatment.
Secondary Outcomes: Rate of decline in pre & post bronchodilator FEV1, FVC & SVC from day 1 until 30 days post treatment, rate of decline in pre & post bronchodilator FVC & SVC day 30 until completion of treatment, exacerbations/hospitalizations, SGRQ total score, mortality
Expected Total Enrollment: 6000
Secondary Outcomes: Rate of decline in pre & post bronchodilator FEV1, FVC & SVC from day 1 until 30 days post treatment, rate of decline in pre & post bronchodilator FVC & SVC day 30 until completion of treatment, exacerbations/hospitalizations, SGRQ total score, mortality
Expected Total Enrollment: 6000
Study start: December 2002; Study completion: October 2008
Eligibility
Ages Eligible for Study: 40 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion criteria: patients >= 40 years of age, with smoking history of >= 10 pack-years, a diagnosis of COPD, FEV1 <= 70% of predicted normal and FEV1 <=70% of FVC Exclusion criteria: significant diseases other than COPD, recent MI (,6 mo.), unstable/lifethreatening arrhythmia or cardiac arrhythmia requiring change in therapy in past year, hospitalization for class III or IV heart failure in past year, asthma, cystic fibrosis, interstitial lung disease, bronchiectasis or pulmonary thromboembolic disease, thoracotomy with pulmonary resection, malignancy in past 5 years, planned lung transplant or LVRS, respiratory infection or exacerbation in 4 weeks preceding screening, moderate to severe renal impairment, narrow angle glaucome, significant symptomatic BPH or bladder neck obstruction, supplemental oxygen >12 hours/day, hypersensitivity to anticholinergic drugs or components of the delivery system.
Location Information
Alabama
Boehringer Ingelheim Investigational Site, Jasper, Alabama, United States
Boehringer Ingelheim Investigational Site, Birmingham, Alabama, United States
Boehringer Ingelheim Investigational Site, Anniston, Alabama, United States
Boehringer Ingelheim Investigational Site, Birmingham, Alabama, United States
Boehringer Ingelheim Investigational Site, Mobile, Alabama, United States
Arizona
Boehringer Ingelheim Investigational Site, Phoenix, Arizona, United States
California
Boehringer Ingelheim Investigational Site, San Diego, California, United States
Boehringer Ingelheim Investigational Site, Los Angeles, California, United States
Boehringer Ingelheim Investigational Site, Los Angeles, California, United States
Boehringer Ingelheim Investigational Site, Carmichael, California, United States
Boehringer Ingelheim Investigational Site, Los Angeles, California, United States
Boehringer Ingelheim Investigational Site, Escondito, California, United States
Boehringer Ingelheim Investigational Site, San Diego, California, United States
Boehringer Ingelheim Investigational Site, Orange, California, United States
Boehringer Ingelheim Investigational Site, Rancho Mirage, California, United States
Boehringer Ingelheim Investigational Site, Los Angeles, California, United States
Boehringer Ingelheim Investigational Site, Lakewood, California, United States
Boehringer Ingelheim Investigational Site, Palo Alto, California, United States
Boehringer Ingelheim Investigational Site, Long Beach, California, United States
Boehringer Ingelheim Investigational Site, Sylmar, California, United States
Boehringer Ingelheim Investigational Site, Stockton, California, United States
Boehringer Ingelheim Investigational Site, San Diego, California, United States
Boehringer Ingelheim Investigational Site, La Jolla, California, United States
Boehringer Ingelheim Investigational Site, Long Beach, California, United States
Boehringer Ingelheim Investigational Site, Sepulveda, California, United States
Colorado
Boehringer Ingelheim Investigational Site, Denver, Colorado, United States
Boehringer Ingelheim Investigational Site, Wheat Ridge, Colorado, United States
Connecticut
Boehringer Ingelheim Investigational Site, Hartford, Connecticut, United States
Boehringer Ingelheim Investigational Site, Norwalk, Connecticut, United States
Boehringer Ingelheim Investigational Site, West Haven, Connecticut, United States
Boehringer Ingelheim Investigational Site, Hartford, Connecticut, United States
Florida
Boehringer Ingelheim Investigational Site, Panama City, Florida, United States
Boehringer Ingelheim Investigational Site, Largo, Florida, United States
Boehringer Ingelheim Investigational Site, Brandon, Florida, United States
Boehringer Ingelheim Investigational Site, Bay Pines, Florida, United States
Boehringer Ingelheim Investigational Site, Melbourne, Florida, United States
Boehringer Ingelheim Investigational Site, Melbourne, Florida, United States
Boehringer Ingelheim Investigational Site, West Palm Beach, Florida, United States
Boehringer Ingelheim Investigational Site, Sarasota, Florida, United States
Boehringer Ingelheim Investigational Site, Tampa, Florida, United States
Georgia
Boehringer Ingelheim Investigational Site, Atlanta, Georgia, United States
Boehringer Ingelheim Investigational Site, Atlanta, Georgia, United States
Boehringer Ingelheim Investigational Site, Stockbridge, Georgia, United States
Boehringer Ingelheim Investigational Site, Augusta, Georgia, United States
Idaho
Boehringer Ingelheim Investigational Site, Coeur D Alene, Idaho, United States
Illinois
Boehringer Ingelheim Investigational Site, Normal, Illinois, United States
Indiana
Boehringer Ingelheim Investigational Site, Indianapolis, Indiana, United States
Iowa
Boehringer Ingelheim Investigational Site, Dubuque, Iowa, United States
Kansas
Boehringer Ingelheim Investigational Site, Olathe, Kansas, United States
Kentucky
Boehringer Ingelheim Investigational Site, Lexington, Kentucky, United States
Louisiana
Boehringer Ingelheim Investigational Site, Shreveport, Louisiana, United States
Boehringer Ingelheim Investigational Site, New Orleans, Louisiana, United States
Maine
Boehringer Ingelheim Investigational Site, Auburn, Maine, United States
Maryland
Boehringer Ingelheim Investigational Site, Baltimore, Maryland, United States
Massachusetts
Boehringer Ingelheim Investigational Site, Boston, Massachusetts, United States
Michigan
Boehringer Ingelheim Investigational Site, Livonia, Michigan, United States
Boehringer Ingelheim Investigational Site, Ann Arbor, Michigan, United States
Boehringer Ingelheim Investigational Site, Detroit, Michigan, United States
Minnesota
Boehringer Ingelheim Investigational Site, Rochester, Minnesota, United States
Boehringer Ingelheim Investigational Site, Minneapolis, Minnesota, United States
Boehringer Ingelheim Investigational Site, Minneapolis, Minnesota, United States
Missouri
Boehringer Ingelheim Investigational Site, Chesterfield, Missouri, United States
Boehringer Ingelheim Investigational Site, Kansas City, Missouri, United States
Boehringer Ingelheim Investigational Site, St. Louis, Missouri, United States
New Hampshire
Boehringer Ingelheim Investigational Site, Lebanon, New Hampshire, United States
New Jersey
Boehringer Ingelheim Investigational Site, Summit, New Jersey, United States
Boehringer Ingelheim Investigational Site, Cherry Hill, New Jersey, United States
New York
Boehringer Ingelheim Investigational Site, Bayshore, New York, United States
Boehringer Ingelheim Investigational Site, Rochester, New York, United States
Boehringer Ingelheim Investigational Site, Larchmont, New York, United States
Boehringer Ingelheim Investigational Site, Manhasset, New York, United States
Boehringer Ingelheim Investigational Site, Bronx, New York, United States
Boehringer Ingelheim Investigational Site, New York, New York, United States
Boehringer Ingelheim Investigational Site, Albany, New York, United States
Boehringer Ingelheim Investigational Site, Mineola, New York, United States
North Carolina
Boehringer Ingelheim Investigational Site, Winston Salem, North Carolina, United States
Boehringer Ingelheim Investigational Site, Burlington, North Carolina, United States
Boehringer Ingelheim Investigational Site, Durham, North Carolina, United States
Boehringer Ingelheim Investigational Site, Chapel Hill, North Carolina, United States
Boehringer Ingelheim Investigational Site, Elizabath City, North Carolina, United States
Ohio
Boehringer Ingelheim Investigational Site, Cincinnati, Ohio, United States
Boehringer Ingelheim Investigational Site, Cleveland, Ohio, United States
Boehringer Ingelheim Investigational Site, Cincinnati, Ohio, United States
Oklahoma
Boehringer Ingelheim Investigational Site, Tulsa, Oklahoma, United States
Oregon
Boehringer Ingelheim Investigational Site, Portland, Oregon, United States
Boehringer Ingelheim Investigational Site, Portland, Oregon, United States
Pennsylvania
Boehringer Ingelheim Investigational Site, Philadelphia, Pennsylvania, United States
Boehringer Ingelheim Investigational Site, Hershey, Pennsylvania, United States
Rhode Island
Boehringer Ingelheim Investigational Site, Providence, Rhode Island, United States
Texas
Boehringer Ingelheim Investigational Site, El Paso, Texas, United States
Boehringer Ingelheim Investigational Site, San Antonio, Texas, United States
Boehringer Ingelheim Investigational Site, Houston, Texas, United States
Boehringer Ingelheim Investigational Site, Houston, Texas, United States
Utah
Boehringer Ingelheim Investigational Site, Salt Lake City, Utah, United States
Virginia
Boehringer Ingelheim Investigational Site, Salem, Virginia, United States
Boehringer Ingelheim Investigational Site, Richmond, Virginia, United States
Boehringer Ingelheim Investigational Site, Lynchburg, Virginia, United States
Boehringer Ingelheim Investigational Site, Fredericksburg, Virginia, United States
Boehringer Ingelheim Investigational Site, Richmond, Virginia, United States
Boehringer Ingelheim Investigational Site, Danville, Virginia, United States
Washington
Boehringer Ingelheim Investigational Site, Spokane, Washington, United States
Wisconsin
Boehringer Ingelheim Investigational Site, La Crosse, Wisconsin, United States
Argentina
Boehringer Ingelheim Investigational Site, Buenos Aies, Argentina
Boehringer Ingelheim Investigational Site, Buenos Aires, Argentina
Boehringer Ingelheim Investigational Site, Buenos Aires, Argentina
Boehringer Ingelheim Investigational Site, Buenos Aires, Argentina
Boehringer Ingelheim Investigational Site, Buenos Aires, Argentina
Boehringer Ingelheim Investigational Site, Buenos Aires, Argentina
Boehringer Ingelheim Investigational Site, Buenos Aires, Argentina
Boehringer Ingelheim Investigational Site, Parque Velez Sarlfield - Córdoba, Argentina
Boehringer Ingelheim Investigational Site, Rosario - Argentina, Argentina
Boehringer Ingelheim Investigational Site, Vicente López- Prov.Buenos Aires, Argentina
Australia, New South Wales
Boehringer Ingelheim Investigational Site, Bankstown, New South Wales, Australia
Boehringer Ingelheim Investigational Site, Concord, New South Wales, Australia
Boehringer Ingelheim Investigational Site, Westmead, New South Wales, Australia
Australia, Queensland
Boehringer Ingelheim Investigational Site, Cairns, Queensland, Australia
Boehringer Ingelheim Investigational Site, Redcliffe, Queensland, Australia
Australia, South Australia
Boehringer Ingelheim Investigational Site, Port Lincoln, South Australia, Australia
Australia, Victoria
Boehringer Ingelheim Investigational Site, Box Hill, Victoria, Australia
Boehringer Ingelheim Investigational Site, Geelong, Victoria, Australia
Austria
Boehringer Ingelheim Investigational Site, Graz, Austria
Boehringer Ingelheim Investigational Site, Innsbruck, Austria
Boehringer Ingelheim Investigational Site, Leoben, Austria
Boehringer Ingelheim Investigational Site, Wien, Austria
Boehringer Ingelheim Investigational Site, Wien, Austria
Belgium
Boehringer Ingelheim Investigational Site, Anderlecht, Belgium
Boehringer Ingelheim Investigational Site, Baudour, Belgium
Boehringer Ingelheim Investigational Site, Brugge, Belgium
Boehringer Ingelheim Investigational Site, Brussel, Belgium
Boehringer Ingelheim Investigational Site, BRUXELLES, Belgium
Boehringer Ingelheim Investigational Site, BRUXELLES, Belgium
Boehringer Ingelheim Investigational Site, Dendermonde, Belgium
Boehringer Ingelheim Investigational Site, Edegem, Belgium
Boehringer Ingelheim Investigational Site, Gent, Belgium
Boehringer Ingelheim Investigational Site, Herentals, Belgium
Boehringer Ingelheim Investigational Site, Ieper, Belgium
Boehringer Ingelheim Investigational Site, Kortrijk, Belgium
Boehringer Ingelheim Investigational Site, Leuven, Belgium
Boehringer Ingelheim Investigational Site, Menen, Belgium
Boehringer Ingelheim Investigational Site, Merksem, Belgium
Boehringer Ingelheim Investigational Site, Middelheim, Belgium
Boehringer Ingelheim Investigational Site, Mons, Belgium
Boehringer Ingelheim Investigational Site, Namur, Belgium
Boehringer Ingelheim Investigational Site, Neerpelt, Belgium
Boehringer Ingelheim Investigational Site, Nobressart (ATTERT), Belgium
Boehringer Ingelheim Investigational Site, Oostende, Belgium
Boehringer Ingelheim Investigational Site, Tournai, Belgium
Boehringer Ingelheim Investigational Site, TURNHOUT, Belgium
Boehringer Ingelheim Investigational Site, TURNHOUT, Belgium
Boehringer Ingelheim Investigational Site, Yvoir, Belgium
Brazil
Boehringer Ingelheim Investigational Site, Florianópolis-SC, Brazil
Boehringer Ingelheim Investigational Site, Juiz de Fora - MG, Brazil
Boehringer Ingelheim Investigational Site, Porto Alegre-RS, Brazil
Boehringer Ingelheim Investigational Site, Porto Alegre-RS, Brazil
Boehringer Ingelheim Investigational Site, Porto Alegre-RS, Brazil
Boehringer Ingelheim Investigational Site, Porto Alegre-RS, Brazil
Boehringer Ingelheim Investigational Site, Porto Alegre-RS, Brazil
Boehringer Ingelheim Investigational Site, Rio de Janeiro - RJ, Brazil
Boehringer Ingelheim Investigational Site, Rio de Janeiro - RJ, Brazil
Boehringer Ingelheim Investigational Site, Salvador - BA, Brazil
Boehringer Ingelheim Investigational Site, Santo André-SP, Brazil
Boehringer Ingelheim Investigational Site, São Paulo-SP, Brazil
Boehringer Ingelheim Investigational Site, São Paulo-SP, Brazil
Boehringer Ingelheim Investigational Site, São Paulo-SP, Brazil
Boehringer Ingelheim Investigational Site, São Paulo-SP, Brazil
Czech Republic
Boehringer Ingelheim Investigational Site, Benesov, Czech Republic
Boehringer Ingelheim Investigational Site, Beroun, Czech Republic
Boehringer Ingelheim Investigational Site, Brno, Czech Republic
Boehringer Ingelheim Investigational Site, Brno, Czech Republic
Boehringer Ingelheim Investigational Site, Cesky Tesin, Czech Republic
Boehringer Ingelheim Investigational Site, HRADEC KRALOVE, Czech Republic
Boehringer Ingelheim Investigational Site, Jablonec nad Nisou, Czech Republic
Boehringer Ingelheim Investigational Site, Jaromer, Czech Republic
Boehringer Ingelheim Investigational Site, Kromeriz, Czech Republic
Boehringer Ingelheim Investigational Site, Kyjov, Czech Republic
Boehringer Ingelheim Investigational Site, Lovosice, Czech Republic
Boehringer Ingelheim Investigational Site, Marianske Lazne, Czech Republic
Boehringer Ingelheim Investigational Site, Plzen, Czech Republic
Boehringer Ingelheim Investigational Site, Plzen, Czech Republic
Boehringer Ingelheim Investigational Site, Prague 5, Czech Republic
Boehringer Ingelheim Investigational Site, Praha 4, Czech Republic
Boehringer Ingelheim Investigational Site, Praha 4, Czech Republic
Boehringer Ingelheim Investigational Site, Praha 5, Czech Republic
Boehringer Ingelheim Investigational Site, Praha 5 - Nove Butovice, Czech Republic
Boehringer Ingelheim Investigational Site, Praha-8, Czech Republic
Boehringer Ingelheim Investigational Site, Prerov, Czech Republic
Boehringer Ingelheim Investigational Site, Pribor, Czech Republic
Boehringer Ingelheim Investigational Site, Strakonice, Czech Republic
Boehringer Ingelheim Investigational Site, Tabor, Czech Republic
Boehringer Ingelheim Investigational Site, Usti nad Orlici, Czech Republic
Boehringer Ingelheim Investigational Site, Znojmo, Czech Republic
Denmark
Boehringer Ingelheim Investigational Site, Aalborg, Denmark
Boehringer Ingelheim Investigational Site, Aalborg SV, Denmark
Boehringer Ingelheim Investigational Site, Copenhagen, Denmark
Boehringer Ingelheim Investigational Site, Copenhagen K, Denmark
Boehringer Ingelheim Investigational Site, Copenhagen Nv, Denmark
Boehringer Ingelheim Investigational Site, Frederikshavn, Denmark
Boehringer Ingelheim Investigational Site, Frederikssund, Denmark
Boehringer Ingelheim Investigational Site, Fåborg, Denmark
Boehringer Ingelheim Investigational Site, Hellerup, Denmark
Boehringer Ingelheim Investigational Site, Hellerup, Denmark
Boehringer Ingelheim Investigational Site, Helsingor, Denmark
Boehringer Ingelheim Investigational Site, Hillerød, Denmark
Boehringer Ingelheim Investigational Site, Hobro, Denmark
Boehringer Ingelheim Investigational Site, Holbæk, Denmark
Boehringer Ingelheim Investigational Site, Holstebro, Denmark
Boehringer Ingelheim Investigational Site, Hvidovre, Denmark
Boehringer Ingelheim Investigational Site, Kalundborg, Denmark
Boehringer Ingelheim Investigational Site, Kolding, Denmark
Boehringer Ingelheim Investigational Site, Nykobing F., Denmark
Boehringer Ingelheim Investigational Site, Næstved, Denmark
Boehringer Ingelheim Investigational Site, Odense C, Denmark
Boehringer Ingelheim Investigational Site, Randers, Denmark
Boehringer Ingelheim Investigational Site, SILKEBORG, Denmark
Boehringer Ingelheim Investigational Site, Skive, Denmark
Boehringer Ingelheim Investigational Site, Skive, Denmark
Boehringer Ingelheim Investigational Site, Skive, Denmark
Boehringer Ingelheim Investigational Site, Slagelse, Denmark
Boehringer Ingelheim Investigational Site, Svendborg, Denmark
Boehringer Ingelheim Investigational Site, Værløse, Denmark
Finland
Boehringer Ingelheim Investigational Site, Helsinki, Finland
Boehringer Ingelheim Investigational Site, Kinkomaa, Finland
Boehringer Ingelheim Investigational Site, Kotka, Finland
Boehringer Ingelheim Investigational Site, Lahti, Finland
Boehringer Ingelheim Investigational Site, Pori, Finland
France
Boehringer Ingelheim Investigational Site, Albi, France
Boehringer Ingelheim Investigational Site, Albi, France
Boehringer Ingelheim Investigational Site, Bourges, France
Boehringer Ingelheim Investigational Site, Barbezieux St Hilaire, France
Boehringer Ingelheim Investigational Site, Chauny, France
Boehringer Ingelheim Investigational Site, Cholet, France
Boehringer Ingelheim Investigational Site, Chamalières, France
Boehringer Ingelheim Investigational Site, La Teste, France
Boehringer Ingelheim Investigational Site, Montauban, France
Boehringer Ingelheim Investigational Site, Nantes, France
Boehringer Ingelheim Investigational Site, Nice, France
Boehringer Ingelheim Investigational Site, Paris, France
Boehringer Ingelheim Investigational Site, Provins, France
Boehringer Ingelheim Investigational Site, Strasbourg, France
Boehringer Ingelheim Investigational Site, Tarbes, France
Boehringer Ingelheim Investigational Site, Toulouse, France
Germany
Boehringer Ingelheim Investigational Site, Berlin, Germany
Boehringer Ingelheim Investigational Site, Berlin, Germany
Boehringer Ingelheim Investigational Site, Brake, Germany
Boehringer Ingelheim Investigational Site, Braunschweig, Germany
Boehringer Ingelheim Investigational Site, Bruchsal, Germany
Boehringer Ingelheim Investigational Site, Hannover, Germany
Boehringer Ingelheim Investigational Site, Kaufbeuren, Germany
Boehringer Ingelheim Investigational Site, Lörrach, Germany
Boehringer Ingelheim Investigational Site, LÜBECK, Germany
Boehringer Ingelheim Investigational Site, München, Germany
Boehringer Ingelheim Investigational Site, München, Germany
Boehringer Ingelheim Investigational Site, Ulm, Germany
Boehringer Ingelheim Investigational Site, Weyhe, Germany
Boehringer Ingelheim Investigational Site, Wiesloch, Germany
Greece
Boehringer Ingelheim Investigational Site, Athens, Greece
Boehringer Ingelheim Investigational Site, Athens, Greece
Boehringer Ingelheim Investigational Site, Heraklion, Greece
Boehringer Ingelheim Investigational Site, Kavala, Greece
Boehringer Ingelheim Investigational Site, Larissa, Greece
Boehringer Ingelheim Investigational Site, Patra, Greece
Boehringer Ingelheim Investigational Site, Patra, Greece
Boehringer Ingelheim Investigational Site, THESSALONIKI, Greece
Boehringer Ingelheim Investigational Site, THESSALONIKI, Greece
Boehringer Ingelheim Investigational Site, THESSALONIKI, Greece
Hong Kong
Boehringer Ingelheim Investigational Site, Hong Kong, Hong Kong
Boehringer Ingelheim Investigational Site, Hong Kong, Hong Kong
Boehringer Ingelheim Investigational Site, Hong Kong, Hong Kong
Boehringer Ingelheim Investigational Site, Kowloon, Hong Kong
Hungary
Boehringer Ingelheim Investigational Site, Budapest, Hungary
Boehringer Ingelheim Investigational Site, Budapest, Hungary
Boehringer Ingelheim Investigational Site, Budapest, Hungary
Boehringer Ingelheim Investigational Site, Budapest, Hungary
Boehringer Ingelheim Investigational Site, Budapest, Hungary
Boehringer Ingelheim Investigational Site, Budapest, Hungary
Boehringer Ingelheim Investigational Site, Debrecen, Hungary
Boehringer Ingelheim Investigational Site, Deszk, Hungary
Boehringer Ingelheim Investigational Site, Erd, Hungary
Boehringer Ingelheim Investigational Site, Farkasgyepü, Hungary
Boehringer Ingelheim Investigational Site, Gyula, Hungary
Boehringer Ingelheim Investigational Site, Kiskunhalas, Hungary
Boehringer Ingelheim Investigational Site, Miskolc, Hungary
Boehringer Ingelheim Investigational Site, Mosonmagyarovar, Hungary
Boehringer Ingelheim Investigational Site, Pecs, Hungary
Boehringer Ingelheim Investigational Site, Sopron, Hungary
Boehringer Ingelheim Investigational Site, Szombathely, Hungary
Boehringer Ingelheim Investigational Site, Tatabanya, Hungary
Boehringer Ingelheim Investigational Site, Törökbalint, Hungary
Boehringer Ingelheim Investigational Site, Veszprem, Hungary
Ireland
Boehringer Ingelheim Investigational Site, Cork, Ireland
Boehringer Ingelheim Investigational Site, Dublin, Ireland
Boehringer Ingelheim Investigational Site, Dublin, Ireland
Boehringer Ingelheim Investigational Site, Dublin, Ireland
Italy
Boehringer Ingelheim Investigational Site, Alessandria, Italy
Boehringer Ingelheim Investigational Site, Avellino, Italy
Boehringer Ingelheim Investigational Site, Bologna, Italy
Boehringer Ingelheim Investigational Site, Busto Arsizio (VA), Italy
Boehringer Ingelheim Investigational Site, CASSANO D''''ADDA (Milano), Italy
Boehringer Ingelheim Investigational Site, Cagliari, Italy
Boehringer Ingelheim Investigational Site, Carrara (Massa), Italy
Boehringer Ingelheim Investigational Site, Chieti, Italy
Boehringer Ingelheim Investigational Site, Erice (Trapani), Italy
Boehringer Ingelheim Investigational Site, Firenze, Italy
Boehringer Ingelheim Investigational Site, Ferrara, Italy
Boehringer Ingelheim Investigational Site, Firenze, Italy
Boehringer Ingelheim Investigational Site, Genova, Italy
Boehringer Ingelheim Investigational Site, Gubbio (Perugia), Italy
Boehringer Ingelheim Investigational Site, Iglesias (Cagliari), Italy
Boehringer Ingelheim Investigational Site, L''''Aquila, Italy
Boehringer Ingelheim

Not Signed In -